Keyphrases
Tumor
76%
Transcription Factor E3 (TFE3)
70%
TERT Promoter mutation
66%
Translocation Renal Cell Carcinoma
64%
Overexpression
62%
Phospholipase D1 (PLD1)
58%
Urothelial Carcinoma
58%
Rat Fibroblasts
58%
Phospholipase D Activity
49%
Phospholipase D
46%
Renal Cell Carcinoma
44%
Protein Kinase
41%
Genetic Modification
36%
Tyrosine Kinase
34%
C-Src
33%
Overexpressing
32%
Urinary Bladder
32%
Epidermal Growth Factor Receptor
31%
Presenilin
30%
TFE3 Gene
30%
Dephosphorylation
29%
N-terminal Domain
29%
Non-small Cell Lung Cancer (NSCLC)
29%
Telomerase Reverse Transcriptase Promoter mutation
29%
Single Institution
29%
Small Cell Carcinoma
29%
Malignancy
26%
Immunohistochemistry
25%
Glandular Lesions
25%
Phosphotyrosine
24%
Upper Tract Urothelial Carcinoma
23%
Apoptosis
23%
Amyloid Precursor Protein
23%
Phospholipase D2 (PLD2)
23%
Carcinoma
22%
Breast Cancer
22%
Primary Adenocarcinoma
22%
Bladder
21%
Protein Expression
21%
Formalin-fixed Paraffin-embedded Tissue
21%
Malignant Neoplasms
19%
Serum Withdrawal
18%
Synaptojanin
18%
Pathologist
18%
V-Src
17%
Mutation Status
17%
Epidermal Growth Factor
17%
Survival Signaling
17%
Molecular Characteristics
17%
Somatic mutation
17%
Medicine and Dentistry
Neoplasm
100%
Promoter Region
98%
Transitional Cell Carcinoma
85%
Clear Cell Renal Cell Carcinoma
72%
Malignant Neoplasm
64%
Bladder
46%
Adenocarcinoma
44%
Immunohistochemistry
38%
Cancer
34%
Biological Marker
33%
Non Small Cell Lung Cancer
29%
Small-Cell Carcinoma
29%
Telomerase Reverse Transcriptase
29%
Gene Mutation
28%
Morphology
27%
Diagnosis
26%
Metastatic Carcinoma
25%
Carcinoma
24%
Adenoma
24%
Breast Cancer
24%
Next Generation Sequencing
23%
Protein Expression
21%
Gene Fusion
19%
Fluorescence in Situ Hybridization
18%
Breast Carcinoma
17%
Estrogen Receptor
17%
Somatic Mutation
17%
Somatics
16%
Alveolar Soft Part Sarcoma
16%
Pathologist
16%
Squamous Cell Carcinoma
15%
Surgery
15%
Lymphoma
14%
Genotype
14%
down Regulation
14%
Hematopoietic System Malignancy
14%
Neoadjuvant Therapy
14%
Lung Adenocarcinoma
14%
Epidermal Growth Factor Receptor 2
14%
Gamma Urogastrone
14%
Synapsin I
14%
Absence
14%
Bone Tissue
14%
Anaplastic Lymphoma Kinase
14%
Dysplasia
14%
microRNA 200c
14%
Inflammatory Bowel Disease
14%
BRCA1
14%
Urogenital Tract Tumor
14%
Signal Transduction
14%
Biochemistry, Genetics and Molecular Biology
TFE3
68%
Phospholipase D
64%
Fibroblast
55%
Epidermal Growth Factor Receptor
55%
Phospholipase D1
44%
Presenilin
30%
STAT1
29%
Next Generation Sequencing
29%
Gene Fusion
27%
down Regulation
26%
Protein Kinase C
25%
Tyrosine Kinase
25%
Receptor Tyrosine Kinase
25%
Dephosphorylation
23%
N-Terminus
23%
Amyloid Precursor Protein
23%
PLD2
20%
Fluorescence in Situ Hybridization
19%
Amyloid
19%
Genetics
18%
Synaptojanin
18%
Oncogene Src
18%
Epidermal Growth Factor
18%
Protein Expression
17%
Messenger RNA
15%
Mouse Model
15%
Disease Free Survival
15%
XIAP
14%
Apolipoprotein
14%
Phospholipid
14%
Neurite Outgrowth
14%
BRCA1
14%
Cancer Cell
14%
Somatic Mutation
14%
Protein Targeting
14%
Synapsin I
14%
RNA Sequencing
14%
B Cell
14%
Gene Dosage
14%
Chromosome 8
14%
Estrogen Receptor
14%
Aggression
14%
Immunostaining
14%
Survival Time
14%
Reverse Transcription Polymerase Chain Reaction
13%
Gene Mutation
12%
TFEB
11%
Dimerization
10%
Chromosomal Translocation
10%
Karyotype
9%